For OB/GYN Clinicians · Early Access

OB/GYN care that
continues between visits.

BreatheOS gives OB/GYN teams a passive breathwork device and telemetry to support postpartum recovery between visits.

JMIR-Published Pilot Clinician Workflow Preview
Request Clinician Early Access
01 / Peer-reviewed feasibility study · Device evidence

Evidence for the device. A preview for the workflow.

Before the clinician portal is generally available, the BreatheOS device has published feasibility evidence. A single-arm prospective cohort with 40 postpartum participants at Women & Infants Hospital, affiliated with Brown University, was published in JMIR Formative Research.

40

Pilot participants

Participants enrolled in the structured BreatheOS device protocol.

25%

Mean HRV improvement

Increase in mean HRV observed during a single session; the paired effect size was minimal.

83%

Acceptability

33 of 40 participants were mostly or very satisfied with the device.

Published in JMIR Formative Research · DOI: 10.2196/85321
“Feasibility and Acceptability of Just Breathe, A Novel Handheld Mindful Breathing Device, for Postpartum Stress: Pilot, Single-Arm Pre-Post Study” — Women & Infants Hospital, affiliated with Brown University, 2026

These are pilot findings about the BreatheOS device. The clinician portal shown here is an early-access preview, not a currently available clinical system.

02 / MamaLift context · Workflow distinction

Different tools, same goal: better postpartum support.

Published app-based evidence is useful context for clinicians. BreatheOS takes a different route by pairing a hardware device with passive breathwork and biometric telemetry.

Published app-based benchmark

MamaLift Plus

MamaLift Plus's published SuMMER trial is a meaningful reference point for postpartum care. The app-only intervention reported EPDS improvement in 86.3% of participants versus 23.9% of controls.

86.3% vs 23.9%EPDS improvement · intervention vs. control · JMIR 2025
Where BreatheOS differs

A hardware layer for passive care.

BreatheOS combines a smart biofeedback device with passive airflow guidance and biometric/session telemetry. It adds a device layer for postpartum support rather than presenting an app-only intervention.

  • Passive breathwork without active coaching during a session
  • Biometric and session telemetry from the device
  • A clinician workflow preview for between-visit follow-up
Preview status: Screening alerts, per-patient timelines, and EHI export are roadmap capabilities for clinician early access. They are not live portal features or current clinical outcomes.
03 / Competitive context · 2026 research

Why BreatheOS vs. CalmiGo.

The 2026 research hub competitive teardown highlights a different path: BreatheOS pairs a smart biofeedback device with a clinical platform, while CalmiGo is assessed as a handheld breath pacer without the same clinical data layer.

Research dimension
BreatheOS
CalmiGo
Real-time respiration biofeedback
Yes — smart biofeedback device
No biometric monitoring
Clinical data layer
Clinical provider dashboard; outcome data / EPDS tracking
No software platform; no clinical dashboard; no outcome data / EPDS tracking
Perinatal-specific program
Yes
No — not perinatal-specific

Source: 2026 research hub competitive teardown.

04 / Clinician preview · Common questions

What clinicians can expect.

A grounded look at the device evidence, clinician workflow preview, and what is still on the roadmap.

Will EPDS scores export to my EHR?
The preview references clinical provider outcome data / EPDS tracking and identifies EHI export as a roadmap capability for clinician early access. EHI export is not a live portal feature in the current preview, and no specific EHR integration is promised.
When does the clinician portal launch?
No launch date is given on this page. The clinician portal is an early-access preview, and early access includes onboarding-window updates plus a clinician workflow walkthrough as the portal moves toward availability.
Is this HIPAA-compliant?
The current clinician preview does not make a HIPAA-compliance claim. It is described as an early-access preview rather than a currently available clinical system.
What does the BreatheOS device actually measure?
The BreatheOS device is a smart biofeedback device with passive airflow guidance, biometric/session telemetry, and real-time respiration biofeedback. The pilot reported a 25% single-session mean HRV increase with minimal paired effect size. The preview distinguishes these pilot physiological findings from current clinical outcomes.
05 / OB/GYN Clinician Early Access

Help shape the workflow between visits.

Early access includes onboarding-window updates and a clinician workflow walkthrough as the portal moves toward availability. Submit your practice email; we'll confirm your request and follow up as preview windows open.

For OB/GYN clinicians only · We won't share your address · No spam

Thanks — we'll confirm your request and be in touch as clinician preview windows open.